Stock News
Alkermes Plc [ALKS] Set For More Gains Ahead of Nov 15th FDA Decision
Alkermes Plc [NASDAQ: ALKS] stock rose significantly on Monday after the company’s bipolar and schizophrenia treatment got a positive review in the wake of the
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.